San Francisco Roundtable

The process by which clinical trial agreements (CTAs) are developed and negotiated often has a tremendous impact on study start-up. There are many challenges involved in negotiating global CTAs – but a number of these challenges can be averted with proper planning and executing negotiation strategies that minimize timelines and maximize start-up efficiency.

Join the discussion with our expert panel, as we share the best practices, lessons learned and key planning assumptions – to both accelerate the completion of CTAs with your sites, while building strong relationships.

Key takeaways from the session include:

• Best practices, methods and partnerships you must create to assist in removing the major barrier to fast start-up
• Drafting and negotiating techniques to minimize disputes and maximize efficiency
• Managing risk within the “Big 5” sections of the CTA

Please use the form to register for the roundtable.